Equities research analysts expect Sapiens International Co. (NASDAQ:SPNS) to report sales of $70.63 million for the current quarter, according to Zacks. Two analysts have provided estimates for Sapiens International’s earnings, with the highest sales estimate coming in at $71.20 million and the lowest estimate coming in at $70.06 million. Sapiens International posted sales of $69.05 million in the same quarter last year, which would indicate a positive year over year growth rate of 2.3%. The firm is scheduled to report its next earnings report on Monday, August 6th.
According to Zacks, analysts expect that Sapiens International will report full year sales of $284.81 million for the current fiscal year, with estimates ranging from $284.61 million to $285.00 million. For the next financial year, analysts forecast that the business will report sales of $299.20 million per share. Zacks’ sales averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Sapiens International.
Sapiens International (NASDAQ:SPNS) last announced its quarterly earnings results on Thursday, March 8th. The technology company reported $0.11 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.11. The company had revenue of $72.40 million during the quarter, compared to the consensus estimate of $72.09 million. Sapiens International had a return on equity of 9.22% and a net margin of 1.90%. Sapiens International’s revenue for the quarter was up 26.8% on a year-over-year basis. During the same period in the previous year, the business earned $0.12 EPS.
A number of brokerages have issued reports on SPNS. Zacks Investment Research raised Sapiens International from a “hold” rating to a “buy” rating and set a $11.00 price target for the company in a report on Wednesday, May 9th. William Blair downgraded Sapiens International from an “outperform” rating to a “market perform” rating in a report on Tuesday, May 8th. BidaskClub downgraded Sapiens International from a “hold” rating to a “sell” rating in a report on Friday, May 4th. Finally, Barclays downgraded Sapiens International from an “overweight” rating to an “equal weight” rating in a report on Friday, February 16th. One research analyst has rated the stock with a sell rating, three have given a hold rating and two have issued a buy rating to the stock. Sapiens International currently has a consensus rating of “Hold” and a consensus price target of $12.50.
Institutional investors and hedge funds have recently bought and sold shares of the company. Kingfisher Capital LLC acquired a new stake in shares of Sapiens International during the fourth quarter worth about $118,000. ARK Investment Management LLC acquired a new stake in shares of Sapiens International during the fourth quarter worth about $213,000. Jane Street Group LLC increased its position in shares of Sapiens International by 105.5% during the first quarter. Jane Street Group LLC now owns 31,988 shares of the technology company’s stock worth $273,000 after purchasing an additional 16,420 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of Sapiens International by 23.2% during the third quarter. Dimensional Fund Advisors LP now owns 39,359 shares of the technology company’s stock worth $520,000 after purchasing an additional 7,400 shares in the last quarter. Finally, Meitav Dash Investments Ltd. acquired a new stake in shares of Sapiens International during the fourth quarter worth about $554,000. Institutional investors and hedge funds own 10.36% of the company’s stock.
Shares of Sapiens International opened at $9.30 on Thursday, according to Marketbeat Ratings. The stock has a market cap of $464.44 million, a price-to-earnings ratio of 24.55, a price-to-earnings-growth ratio of 4.01 and a beta of 1.20. The company has a quick ratio of 1.46, a current ratio of 1.46 and a debt-to-equity ratio of 0.33. Sapiens International has a 1 year low of $9.34 and a 1 year high of $9.34.
Sapiens International Company Profile
Sapiens International Corporation N.V. provides software solutions for the insurance and financial services industries in North America, Europe, the Asia Pacific, and South Africa. The company offers software platform and solutions for life, pension, and annuities, such as Sapiens ALIS, LifeSuite, Life Portraits, LifeApply, Sapiens INSIGHT, and Sapiens Closed Books; and personal, commercial and specialty lines, and workers' compensation comprising Sapiens IDIT, Adaptik Policy, Adaptik Billing, Stream Claim, Sapiens Stingray, PowerSuite, and CompSuite.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sapiens International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sapiens International and related companies with MarketBeat.com's FREE daily email newsletter.